The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer

Research output: Contribution to journalEditorial

2 Scopus citations
Original languageEnglish
Pages (from-to)153-155
Number of pages3
JournalJournal of Thoracic Disease
Volume12
Issue number3
DOIs
StatePublished - 1 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this